Purpose: Childhood stuttering is common and can have debilitating, long-term psychosocial implications if prompt and effective treatment is not provided. The Lidcombe Program has robust clinical evidence for treating stuttering in early childhood. The results of a recent Phase II trial with a cohort of 6–12-year-old children showed that this treatment may benefit a much broader age range of children than initially thought. Benefits included improved communication attitudes, and reduced impact of stuttering and social anxiety symptoms. This study describes how clinicians can use the Lidcombe Program flexibly to cater to the varied needs of older children.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: